Inventor · disambiguated record
Peter Wisdom Atadja
Also filed as: ATADJA PETER W · ATADJA PETER WISDOM
2 granted patents·26 pending applications·21 citations·filing 2001–2018
60Inventor score
Top patents by PatentIndex Score
28 records- 0179US8093220B2Combination of an HDAC inhibitor and an antimetaboliteATADJA PETER WISDOM·Filed 2007·Granted Jan 10, 2012·16 cites·3 claims
- 0269US8883842B2Use of HDAC inhibitors for the treatment of myelomaATADJA PETER W·Filed 2010·Granted Nov 11, 2014·5 cites·2 claims
- 0361US2018289670A1Combination of lbh589 with other therapeutic agents for treating cancerNOVARTIS AG·Filed 2018·Application pending·0 cites
- 0459US2018071251A1Combination of lbh589 with other therapeutic agents for treating cancerNOVARTIS AG·Filed 2017·Application pending·0 cites
- 0558US2017246147A1Combination of lbh589 with other therapeutic agents for treating cancerNOVARTIS AG·Filed 2017·Application pending·0 cites
- 0657US2010069458A1Combination of lbh589 with other therapeutic agents for treating cancerATADJA PETER WISDOM·Filed 2008·Application pending·0 cites
- 0757US2015094274A1Combination of lbh589 with other therapeutic agents for treating cancerATADJA PETER WISDOM·Filed 2014·Application pending·0 cites
- 0856US2017027909A1Combinations of therapeutic agents for treating cancerNOVARTIS AG·Filed 2016·Application pending·0 cites
- 0952US2013029927A1Combination of lbh589 with other therapeutic agents for treating cancerATADJA PETER WISDOM·Filed 2012·Application pending·0 cites
- 1050US2010179208A1Use of HDAC Inhibitors for the Treatment of Bone DestructionNOVARTIS AG·Filed 2008·Application pending·0 cites
- 1150US2011034531A1Use of hdac inhibitors for the treatment of melanomaNOVARTIS AG·Filed 2008·Application pending·0 cites
- 1249US2010137398A1Use of hdac inhibitors for the treatment of gastrointestinal cancersNOVARTIS AG·Filed 2008·Application pending·0 cites
- 1348US2008200489A1Combination of Organic CompoundsATADJA PETER WISDOM·Filed 2006·Application pending·0 cites
- 1447US2007123580A1Combination of histone deacetylase inhibitors with chemotherapeutic agentsATADJA PETER W·Filed 2004·Application pending·0 cites
- 1547US2009281159A1Use of hdac inhibitors for the treatment of lymphomasNOVARTIS AG·Filed 2007·Application pending·0 cites
- 1646US2011124701A1Use of hdac inhibitors for the treatment of lymphomasNOVARTIS AG·Filed 2010·Application pending·0 cites
- 1742US2013171141A1Combination of hdac inhibitors with thrombocytopenia drugsATADJA PETER WISDOM·Filed 2011·Application pending·0 cites
- 1841US2011118309A1Use of hdac inhibitors for the treatment of hodgkin's diseaseATADJA PETER WISDOM·Filed 2009·Application pending·0 cites
- 1940US2008221126A1Use of Hdac Inhibitors for the Treatment of MyelomaATADJA PETER W·Filed 2006·Application pending·0 cites
- 2040US2007134744A1Epothilone resistant cell linesATADJA PETER W·Filed 2007·Application pending·0 cites
- 2139US2016199350A1Combination of hdac inhibitors with thrombocytopenia drugsATADJA PETER WISDOM·Filed 2015·Application pending·0 cites
- 2238US2007191338A1Combinations comprising staurosporinesATADJA PETER W·Filed 2004·Application pending·0 cites
- 2337US2005118596A1Method for screening for compounds having hdac inhibitory activityFiled 2003·Application pending·0 cites
- 2437US2007258972A1Combination of a Histone Deacetylase Inhibitor with a Death Receptor LigandATADJA PETER W·Filed 2004·Application pending·0 cites
- 2535US2012029047A1Use of hdac inhibitors for the treatment of bone destructionATADJA PETER WISDOM·Filed 2011·Application pending·0 cites
- 2635US2004038324A1Epothilone resistant cell linesFiled 2001·Application pending·0 cites
- 2735US2011288144A1Use of hdac inhibitors for the treatment of melanomaATADJA PETER WISDOM·Filed 2011·Application pending·0 cites
- 2835US2005227300A1Use of alpha-tubulin acetylation levels as a biomarker for protein deacetylase inhibitorsATADJA PETER W·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peter Wisdom Atadja files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →